Knowledge, Attitudes and Referral Patterns of Lynch Syndrome: A Survey of Clinicians in Australia

This study assessed Australian clinicians’ knowledge, attitudes and referral patterns of patients with suspected Lynch syndrome for genetic services. A total of 144 oncologists, surgeons, gynaecologists, general practitioners and gastroenterologists from the Australian Medical Association and Clinical Oncology Society responded to a web-based survey. Most respondents demonstrated suboptimal knowledge of Lynch syndrome. Male general practitioners who have been practicing for ≥10 years were less likely to offer genetic referral than specialists, and many clinicians did not recognize that immunohistochemistry testing is not a germline test. Half of all general practitioners did not actually refer patients in the past 12 months, and 30% of them did not feel that their role is to identify patients for genetic referral. The majority of clinicians considered everyone to be responsible for making the initial referral to genetic services, but a small preference was given to oncologists (15%) and general practitioners (13%). Patient information brochures, continuing genetic education programs and referral guidelines were favoured as support for practice. Targeted education interventions should be considered to improve referral. An online family history assessment tool with built-in decision support would be helpful in triaging high-risk individuals for pathology analysis and/or genetic assessment in general practice.

[1]  L. Fitzgerald,et al.  Barriers and Motivators for Referral of Patients with Suspected Lynch Syndrome to Cancer Genetic Services: A Qualitative Study , 2014, Journal of personalized medicine.

[2]  Alexander M. Metcalf,et al.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Spurdle,et al.  Referral of Patients with Suspected Hereditary Breast-Ovarian Cancer or Lynch Syndrome for Genetic Services: A Systematic Review , 2013 .

[4]  D. Khayat,et al.  Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests , 2013, Breast Cancer Research and Treatment.

[5]  A. Spurdle,et al.  Improving identification of lynch syndrome patients: A comparison of research data with clinical records , 2013, International journal of cancer.

[6]  Alison B. Hamilton,et al.  A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians , 2013, Genetics in Medicine.

[7]  T. Cornelison,et al.  Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome , 2013, Cancer Prevention Research.

[8]  D. Evans,et al.  Cancer risk in Lynch Syndrome , 2013, Familial Cancer.

[9]  T. Le,et al.  Epidemiology and investigations for suspected endometrial cancer. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[10]  Aung Ko Win,et al.  Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. , 2013, Journal of the National Cancer Institute.

[11]  P. Møller,et al.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.

[12]  A. Zlot,et al.  Patterns of Cancer Genetic Testing: A Randomized Survey of Oregon Clinicians , 2012, Journal of cancer epidemiology.

[13]  M. Frey,et al.  Lynch Syndrome: Awareness among Medical Students at a United States Medical School , 2012, Current women's health reviews.

[14]  Lisa J. Martin,et al.  Barriers to and Motivations for Physician Referral of Patients to Cancer Genetics Clinics , 2012, Journal of Genetic Counseling.

[15]  L. Kiemeney,et al.  Adequacy of family history taking in ovarian cancer patients: a population-based study , 2012, Familial Cancer.

[16]  J. Ledermann,et al.  Family History and Women With Ovarian Cancer: Is it Asked and Does it Matter? , 2011, International Journal of Gynecologic Cancer.

[17]  Guyonne Kalb,et al.  A randomised trial and economic evaluation of the effect of response mode on response rate, response bias, and item non-response in a survey of doctors , 2011, BMC medical research methodology.

[18]  J. Duffy,et al.  "For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer. , 2011, Genetic testing and molecular biomarkers.

[19]  C. Boland,et al.  Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population , 2010, Cancer Prevention Research.

[20]  Hardeep Singh,et al.  Underdiagnosis of Lynch syndrome involves more than family history criteria. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  Jukka-Pekka Mecklin,et al.  Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Kimberly M. Kelly,et al.  Cancer risk assessment by rural and Appalachian family medicine physicians. , 2009, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[23]  P. Raina,et al.  The current state of cancer family history collection tools in primary care: a systematic review , 2009, Genetics in Medicine.

[24]  L. Vatten,et al.  Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population‐based study , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[25]  P. Bendahl,et al.  Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels , 2009, BMC Medical Genetics.

[26]  P. Goodson,et al.  US health educators' likelihood of adopting genomic competencies into health promotion. , 2008, American journal of public health.

[27]  P. Gibbs,et al.  Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing? , 2008, Internal medicine journal.

[28]  E. Grunfeld,et al.  Genetic Services for Hereditary Breast/Ovarian and Colorectal Cancers – Physicians’ Awareness, Use and Satisfaction , 2008, Public Health Genomics.

[29]  J. Kirk,et al.  Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types. , 2007, Genetic testing.

[30]  B. Karlan,et al.  Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. , 2007, Gynecologic oncology.

[31]  P. Raina,et al.  Collection and use of cancer family history in primary care. , 2007, Evidence report/technology assessment.

[32]  J. Emery,et al.  The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care , 2007, British Journal of Cancer.

[33]  M. Aitken,et al.  A model for the development of genetics education programs for health professionals , 2007, Genetics in Medicine.

[34]  J. Edwards,et al.  Lost in transition: Challenges in the expanding field of adult genetics , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[35]  J. Kleibeuker,et al.  Decrease in mortality in Lynch syndrome families because of surveillance. , 2006, Gastroenterology.

[36]  M. Munsell,et al.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.

[37]  G. Suthers,et al.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder , 2005, Journal of Medical Genetics.

[38]  K. Stange,et al.  Clinical genetics issues encountered by family physicians , 2005, Genetics in Medicine.

[39]  D. Macauley,et al.  Genetic consultations in primary care: GPs’ responses to three scenarios , 2005, Scandinavian journal of primary health care.

[40]  G. Giles,et al.  Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  E. Stoffel,et al.  Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[43]  Stephen Sutton,et al.  Using the Internet to conduct surveys of health professionals: a valid alternative? , 2003, Family practice.

[44]  T Hyslop,et al.  Use of cancer susceptibility testing among primary care physicians , 2003, Clinical genetics.

[45]  R. Croyle,et al.  US physicians' attitudes toward genetic testing for cancer susceptibility , 2003, American journal of medical genetics. Part A.

[46]  Mehran S Massoudi,et al.  Comparison of e-mail, fax, and postal surveys of pediatricians. , 2003, Pediatrics.

[47]  H. Valdimarsdottir,et al.  Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology , 2002, American Journal of Gastroenterology.

[48]  W. Zoller,et al.  [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. , 2001, Zeitschrift fur Gastroenterologie.

[49]  H. Lynch,et al.  Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer , 1999, Cancer.

[50]  H Campbell,et al.  GPs' views on their role in cancer genetics services and current practice. , 1999, Family practice.

[51]  J. Austoker,et al.  The 'new genetics' and primary care: GPs' views on their role and their educational needs. , 1999, Family practice.

[52]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[53]  Murray Turoff,et al.  The Delphi Method: Techniques and Applications , 1976 .

[54]  Monica R McClain,et al.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome , 2009, Genetics in Medicine.

[55]  Patricia Goodson,et al.  Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature , 2003, Genetics in Medicine.

[56]  B. Gogarty Essentially Yours: The Protection of Human Genetic Information in Australia (ALRC Report 96) , 2003 .

[57]  H. Lynch,et al.  Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer , 1999 .

[58]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .